Surrogate endpoints, part 1 from definition to meta-analytic framework /

Volledige tekst
Series

Surrogate endpoints, part 2 further developments /

Volledige tekst
Series

Randomization, blinding and drug supply in interactive voice response trials

Volledige tekst
Series

Ecological considerations for gene drive systems

Volledige tekst
Series

Guidance for responsible testing and implementation of gene-drive systems

Volledige tekst
Series

Data fusion examples in fusing metabolomics and transcriptomics data /

Volledige tekst
Series

Bridging our mandates evidence-based practice (EBP) and patient-centered care (PCC), part 1 of 2 /

Volledige tekst
Series

Clinical research and care in the era of "N-of-1" precision cancer medicine

Volledige tekst
Series

Bridging our mandates evidence-based practice (EBP) and patient-centered care (PCC), part 2 of 2/

Volledige tekst
Series

Comparing transcriptomes of distant organisms the comparative ENCODE resource, part 1 of 2 /

Volledige tekst
Series

Comparing transcriptomes of distant organisms models of gene expression, part 2 of 2 /

Volledige tekst
Series

Survival analysis

Volledige tekst
Series

Randomization in N-of-1 clinical trials is it possible to draw causal inferences from single-patient data /

Volledige tekst
Series

Introduction to systematic reviews for librarians

Volledige tekst
Series

Teixobactin kills pathogens without detectable resistance

Volledige tekst
Series (Antibiotic resistance)
Series (Small molecule drug discovery)

Manufacturing viral gene therapy vectors general approaches and challenges /

Volledige tekst
Series

Clinical proteomics in gastrointestinal cancers

Volledige tekst
Series

A concept for multi-marker approaches in clinical proteomics

Volledige tekst
Series

Proteomics in cardiovascular disease clinical considerations /

Volledige tekst
Series

Application of proteomics in fetal and neonatal medicine

Volledige tekst
Series